TFF3 and gastric cancer: Further large studies are required to confirm the strong predictive power of serum TFF3 and the combination tests with TFF3 and pepsinogen in patients with AGC or EGC, as well as to clarify the role of serum TFF3 as a nonendoscopic biomarker in population-based screening for gastric cancer.